SlideShare a Scribd company logo
Does Catalonia
Need a Chief Science Officer / Advisor ?
Mehrdad Hariri
CEO & Founder Canadian Science Policy Centre
BioCat Forum
Nov. 25 2016
Hello, Bonjour from CANADA
Global Challenges
New institutions of science policy
Bosch-Capblanch X, Lavis JN, Lewin S, Atun R, Røttingen J-A, Dröschel D, et al. (2012) Guidance for Evidence-Informed Policies
about Health Systems: Rationale for and Challenges of Guidance Development. PLoS Med 9(3): e1001185.
doi:10.1371/journal.pmed.1001185
Cycle of Interaction:
Science Society Policy Maker
Adopted from: http://weadapt.org/
• the complexity, multidisciplinary,
and ever-changing nature of science
and technology of the 21st century
requires efficient, energetic and agile
institutions to ensure the
interconnection among various
elements of innovation system,
including the society at large.
• Sputnik slide
Why science adviser / officer
Officer vs Advisor
Chief Science Officer (CSO) Chief Science Advisor (CSA)
Responsible for capacity development of
the overall science enterprise or
government funded science
Responsible for providing independent
scientific advice to the Prime Minister
and the cabinet
Officer vs Advisor
Chief Science Officer (CSO) Chief Science Advisor (CSA)
Responsible for capacity development of
the overall science enterprise or
government funded science
Responsible for providing independent
scientific advice to the Prime Minister
and the cabinet
Jurisdiction: Policy for Science Jurisdiction: Science for Policy
Officer vs Advisor
Chief Science Officer (CSO) Chief Science Advisor (CSA)
Responsible for capacity development of
the overall science enterprise or
government funded science
Responsible for providing independent
scientific advice to the Prime Minister
and the cabinet
Jurisdiction: Policy for Science Jurisdiction: Science for Policy
Ensures the well-being of the science
enterprise, its management,
coordination, and collaboration,
domestically and internationally
Provides the best scientific advice on
emerging matters for high-level decision-
making.
Officer vs Advisor
Chief Science Officer (CSO) Chief Science Advisor (CSA)
Responsible for capacity development of
the overall science enterprise or
government funded science
Responsible for providing independent
scientific advice to the Prime Minister
and the cabinet
Jurisdiction: Policy for Science Jurisdiction: Science for Policy
CEO of Science Enterprise/ or
Government Science (depending on the
extension of mandate)
No Formal Executive Responsibility
Ensures the well-being of the science
enterprise, its management,
coordination, and collaboration,
domestically and internationally
Provides the best scientific advice on
emerging matters for high-level decision-
making.
Officer vs Advisor
Chief Science Officer (CSO) Chief Science Advisor (CSA)
Responsible for capacity development of
the overall science enterprise or
government funded science
Responsible for providing independent
scientific advice to the Prime Minister
and the cabinet
Jurisdiction: Policy for Science Jurisdiction: Science for Policy
CEO of Science Enterprise/ or
Government Science (depending on the
extension of mandate)
No Formal Executive Responsibility
Functions as part of the Ministry of
Science and or Innovation
Independent, Arm’s Length office,
functioning under the PMO
Ensures the well-being of the science
enterprise, its management,
coordination, and collaboration,
domestically and internationally
Provides the best scientific advice on
emerging matters for high-level decision-
making.
Science Advisory: USA
The Office of Science and Technology Policy
(OSTP) is a department of the United States
government, part of the Executive Office of the
President (EOP), established by the United
States Congress in 1976,
broad mandate to advise the President on the
effects of science and technology on domestic
and international affairs.
Science Advisory: USA
Mission:
1.To provide the President and his senior staff with accurate, relevant,
and timely scientific and technical advice on all matters of consequence;
2.To ensure that the policies of the Executive Branch are informed by
sound science
3.Too ensure that the scientific and technical work of the Executive
Branch is properly coordinated so as to provide the greatest benefit to
society.
Science Advisory: UK
Every government department has a chief scientific Advisor
(CSA).
Departmental CSAs work together under the leadership of the
Government’s Chief Scientific Advisor to support each other
and to address and advise on cross-cutting issues.
They do this primarily through the Chief Scientific Advisors
network. The network advises the Government Chief Scientific
Advisor on all aspects of policy on science and technology.
Science Advisory: UK
In particular, they:
1. Provide advice to ministers, through the Cabinet committee system
2. Discuss and facilitate implementation of policy on science, technology,
engineering and mathematics (STEM)
3. Identify and share good practices in STEM-related areas, including the
use of scientific advice in policy-making
4. Facilitate communication on particular high profile STEM-related issues
and those posing new challenges for government
Science Advisory: New Zealand
Science Advisory: New Zealand
The primary task of the Chief Scientific Advisor is to provide the Prime Minister
strategic and operational advice on science and science policy issues. Other
tasks include:
1.Advise on matters of science policy in areas where the Prime Minister specifically
requests. 
2.Advise Prime Minister on specific matters related to science
3.Promote the public understanding of, and engagement with, science, particularly with
young people.
4.Build international relationships. Science can be an important diplomatic tool, generating
trust and confidence between nations and opening strategic opportunities for cooperation.
5.Serve as a conduit of alerts that might arise where scientific progress shows either
opportunity or threat for New Zealand. 
Science Advisory: Australia
Science Advisory: Australia
The world, and Australia with it, is faced with increasingly complex challenges
and opportunities, most of which require significant input from science in order to
address them fully and appropriately.
It is essential then, that the Australian available, to be used to help inform the
best course of action for Australian Government has access to the highest
calibre independent, and authoritative scientific advice.
The Chief Scientist has the opportunity to help bring together extensive national
and international scientific networks to assist in providing the most up to date and
scientifically robust advice.
Through international networks the Chief Scientist is also able to help discuss
and affect this at a global level. This is a key and unique aspect of the role.
Science and Technology and innovation Council
(STIC)
Scotland
Scotland
Provides expert scientific advice to the Scottish Government
about science-related issues, evidence and new developments
that may have an impact on the Scottish Government's work
Champions the use of science to inform policy development
across the Scottish Government
Supports Scotland's world-leading science base and its potential
to benefit Scotland's economy, people and environment
Quebec
•To advise the Minister of Economy, Science and Innovation
on matters pertaining to the development of research and
science;
•To chair the Boards of Directors of each of the three research
funds;
•To coordinate issues of common concern to the three funds
and cross-sectoral research activities;
•To ensure the consolidation and integration of the three
research funds’ administrative activities;
•To promote careers in research and scientific culture.
Does Catalonia
Need a Chief Science Officer / Advisor ?
Determinant of such office
• Objectives
• Stakeholders consultation
Innovation Systems
Adopted from:
Review of federal support for R&D
QUESTIONS
QUESTIONS

More Related Content

Viewers also liked

Presentation done by Marta Marse Virdi
Presentation done by Marta Marse VirdiPresentation done by Marta Marse Virdi
Presentation done by Marta Marse Virdi
Dr. Amit Kapoor
 
Common Myths In Fitness - 6
Common Myths In Fitness - 6Common Myths In Fitness - 6
Common Myths In Fitness - 6
Miss Bee
 
95501891 jueves-31-de-mayo-de-2012
95501891 jueves-31-de-mayo-de-201295501891 jueves-31-de-mayo-de-2012
95501891 jueves-31-de-mayo-de-2012
Rina Rosa
 
90tools90minutes westmere 19 05-2010
90tools90minutes westmere 19 05-201090tools90minutes westmere 19 05-2010
90tools90minutes westmere 19 05-2010
David Kinane
 
QCL520 Social Studies Interactive Lecture
QCL520 Social Studies Interactive LectureQCL520 Social Studies Interactive Lecture
QCL520 Social Studies Interactive Lecture
Goh Bang Rui
 
Branding Singapore
Branding SingaporeBranding Singapore
Branding Singapore
Shadul Narang
 
Singapore vs India Economically
Singapore vs India EconomicallySingapore vs India Economically
Singapore vs India Economically
Chetana's Institute of Management & Research
 
Una estrategia industrial per a Catalunya
Una estrategia industrial per a CatalunyaUna estrategia industrial per a Catalunya
Una estrategia industrial per a Catalunya
Agència per a la Competitivitat de l'empresa - ACCIÓ
 
Introduction to en world Singapore
Introduction to en world SingaporeIntroduction to en world Singapore
Introduction to en world Singapore
en world
 
Catalonia in-world-competitiveness-report-2014
Catalonia in-world-competitiveness-report-2014Catalonia in-world-competitiveness-report-2014
Catalonia in-world-competitiveness-report-2014
Agència per a la Competitivitat de l'empresa - ACCIÓ
 
Singapore An economic miracle
Singapore An economic miracleSingapore An economic miracle
Singapore An economic miracle
Oto Sikharulidze
 
Macro-Economics Case Analysis: Singapore - a unique economy
Macro-Economics Case Analysis: Singapore - a unique economyMacro-Economics Case Analysis: Singapore - a unique economy
Macro-Economics Case Analysis: Singapore - a unique economy
Madhuranath R
 
Tw22
Tw22Tw22
Financial Markets In Singapore
Financial Markets In SingaporeFinancial Markets In Singapore
Financial Markets In Singapore
Ajay Panandikar
 
Singapur's economic model Office power point
Singapur's economic model Office power pointSingapur's economic model Office power point
Singapur's economic model Office power point
Aidana Andekina
 
Landscape Catalogues: To Improve the Knowledge And To Act. Experiences In Cat...
Landscape Catalogues: To Improve the Knowledge And To Act. Experiences In Cat...Landscape Catalogues: To Improve the Knowledge And To Act. Experiences In Cat...
Landscape Catalogues: To Improve the Knowledge And To Act. Experiences In Cat...
Pere Sala i Martí
 
Chapter 5 - How external events affect Singapore?
Chapter 5 - How external events affect Singapore?Chapter 5 - How external events affect Singapore?
Chapter 5 - How external events affect Singapore?
Irving Quah
 
Intel Roadmap 2010
Intel Roadmap 2010Intel Roadmap 2010
Intel Roadmap 2010
Umair Mohsin
 
Remaking singapore
Remaking singaporeRemaking singapore
Remaking singapore
NIDA Business School
 
Nanotechnology and CHIP Fabrication
Nanotechnology and CHIP FabricationNanotechnology and CHIP Fabrication
Nanotechnology and CHIP Fabrication
মুহম্মাদ হাসান
 

Viewers also liked (20)

Presentation done by Marta Marse Virdi
Presentation done by Marta Marse VirdiPresentation done by Marta Marse Virdi
Presentation done by Marta Marse Virdi
 
Common Myths In Fitness - 6
Common Myths In Fitness - 6Common Myths In Fitness - 6
Common Myths In Fitness - 6
 
95501891 jueves-31-de-mayo-de-2012
95501891 jueves-31-de-mayo-de-201295501891 jueves-31-de-mayo-de-2012
95501891 jueves-31-de-mayo-de-2012
 
90tools90minutes westmere 19 05-2010
90tools90minutes westmere 19 05-201090tools90minutes westmere 19 05-2010
90tools90minutes westmere 19 05-2010
 
QCL520 Social Studies Interactive Lecture
QCL520 Social Studies Interactive LectureQCL520 Social Studies Interactive Lecture
QCL520 Social Studies Interactive Lecture
 
Branding Singapore
Branding SingaporeBranding Singapore
Branding Singapore
 
Singapore vs India Economically
Singapore vs India EconomicallySingapore vs India Economically
Singapore vs India Economically
 
Una estrategia industrial per a Catalunya
Una estrategia industrial per a CatalunyaUna estrategia industrial per a Catalunya
Una estrategia industrial per a Catalunya
 
Introduction to en world Singapore
Introduction to en world SingaporeIntroduction to en world Singapore
Introduction to en world Singapore
 
Catalonia in-world-competitiveness-report-2014
Catalonia in-world-competitiveness-report-2014Catalonia in-world-competitiveness-report-2014
Catalonia in-world-competitiveness-report-2014
 
Singapore An economic miracle
Singapore An economic miracleSingapore An economic miracle
Singapore An economic miracle
 
Macro-Economics Case Analysis: Singapore - a unique economy
Macro-Economics Case Analysis: Singapore - a unique economyMacro-Economics Case Analysis: Singapore - a unique economy
Macro-Economics Case Analysis: Singapore - a unique economy
 
Tw22
Tw22Tw22
Tw22
 
Financial Markets In Singapore
Financial Markets In SingaporeFinancial Markets In Singapore
Financial Markets In Singapore
 
Singapur's economic model Office power point
Singapur's economic model Office power pointSingapur's economic model Office power point
Singapur's economic model Office power point
 
Landscape Catalogues: To Improve the Knowledge And To Act. Experiences In Cat...
Landscape Catalogues: To Improve the Knowledge And To Act. Experiences In Cat...Landscape Catalogues: To Improve the Knowledge And To Act. Experiences In Cat...
Landscape Catalogues: To Improve the Knowledge And To Act. Experiences In Cat...
 
Chapter 5 - How external events affect Singapore?
Chapter 5 - How external events affect Singapore?Chapter 5 - How external events affect Singapore?
Chapter 5 - How external events affect Singapore?
 
Intel Roadmap 2010
Intel Roadmap 2010Intel Roadmap 2010
Intel Roadmap 2010
 
Remaking singapore
Remaking singaporeRemaking singapore
Remaking singapore
 
Nanotechnology and CHIP Fabrication
Nanotechnology and CHIP FabricationNanotechnology and CHIP Fabrication
Nanotechnology and CHIP Fabrication
 

Similar to “Does Catalonia need a Chief Scientist?”, MEHRDAD HARIRI

science_of_science_policy_roadmap_2008
science_of_science_policy_roadmap_2008science_of_science_policy_roadmap_2008
science_of_science_policy_roadmap_2008
Avery Sen
 
Policy Workshop Introduction by Dr Michael Elves
Policy Workshop Introduction by Dr Michael ElvesPolicy Workshop Introduction by Dr Michael Elves
Policy Workshop Introduction by Dr Michael Elves
Jeremy LeLean
 
Science advice to government - Auckland conference
Science advice to government - Auckland conferenceScience advice to government - Auckland conference
Science advice to government - Auckland conference
bis_foresight
 
Science & Technology Communication
Science & Technology CommunicationScience & Technology Communication
NZSR_68
NZSR_68NZSR_68
NZSR_68
Dan McElrea
 
Stevenage Bioscience Catalyst: annual lecture 2014
Stevenage Bioscience Catalyst: annual lecture 2014Stevenage Bioscience Catalyst: annual lecture 2014
Stevenage Bioscience Catalyst: annual lecture 2014
bis_foresight
 
Do you, or do you not, suspect that there is emerging a ‘good’ expla.pdf
Do you, or do you not, suspect that there is emerging a ‘good’ expla.pdfDo you, or do you not, suspect that there is emerging a ‘good’ expla.pdf
Do you, or do you not, suspect that there is emerging a ‘good’ expla.pdf
sanuoptical
 
Science, Technology & Knowledge Economy
Science, Technology & Knowledge Economy Science, Technology & Knowledge Economy
Science, Technology & Knowledge Economy
Sandipan Dhar
 
2010 Mid West Science Summit | Inspiring Australia
2010 Mid West Science Summit | Inspiring Australia2010 Mid West Science Summit | Inspiring Australia
2010 Mid West Science Summit | Inspiring Australia
Geoff Crane
 
ESLTP starter workshop - survey response summary
ESLTP starter workshop - survey response summaryESLTP starter workshop - survey response summary
ESLTP starter workshop - survey response summary
TERN Australia
 
TWAS Opportunities and the Importance of Mobilising Young Scientists in sub-S...
TWAS Opportunities and the Importance of Mobilising Young Scientists in sub-S...TWAS Opportunities and the Importance of Mobilising Young Scientists in sub-S...
TWAS Opportunities and the Importance of Mobilising Young Scientists in sub-S...
Academy of Science of South Africa (ASSAf)
 
Science Diplomacy 101
Science Diplomacy 101Science Diplomacy 101
Science Diplomacy 101
CRDF Global
 
Communicating Science to Policymakers
Communicating Science to PolicymakersCommunicating Science to Policymakers
Communicating Science to Policymakers
Scientists and Engineers for America
 
Overview of ESRC
Overview of ESRCOverview of ESRC
Overview of ESRC
ESRC Communications
 
Alpsp Conf 10 Sep 09
Alpsp Conf 10 Sep 09Alpsp Conf 10 Sep 09
Alpsp Conf 10 Sep 09
Research Information Network
 
Dr andrew kaniki
Dr andrew kanikiDr andrew kaniki
Dr andrew kaniki
SATN
 
Emerging Technologies to Support an Aging Population - BlueStar TeleHealth
Emerging Technologies to Support an Aging Population - BlueStar TeleHealthEmerging Technologies to Support an Aging Population - BlueStar TeleHealth
Emerging Technologies to Support an Aging Population - BlueStar TeleHealth
BlueStar TeleHealth
 
SRUK seminar 8 July 2017
SRUK seminar 8 July 2017SRUK seminar 8 July 2017
SRUK seminar 8 July 2017
Katherine Mathieson
 
{The best technology in number position 2
{The best technology in number position 2{The best technology in number position 2
{The best technology in number position 2
sassyswindler8742
 
{The best technology in number position 3
{The best technology in number position 3{The best technology in number position 3
{The best technology in number position 3
callousearnings47
 

Similar to “Does Catalonia need a Chief Scientist?”, MEHRDAD HARIRI (20)

science_of_science_policy_roadmap_2008
science_of_science_policy_roadmap_2008science_of_science_policy_roadmap_2008
science_of_science_policy_roadmap_2008
 
Policy Workshop Introduction by Dr Michael Elves
Policy Workshop Introduction by Dr Michael ElvesPolicy Workshop Introduction by Dr Michael Elves
Policy Workshop Introduction by Dr Michael Elves
 
Science advice to government - Auckland conference
Science advice to government - Auckland conferenceScience advice to government - Auckland conference
Science advice to government - Auckland conference
 
Science & Technology Communication
Science & Technology CommunicationScience & Technology Communication
Science & Technology Communication
 
NZSR_68
NZSR_68NZSR_68
NZSR_68
 
Stevenage Bioscience Catalyst: annual lecture 2014
Stevenage Bioscience Catalyst: annual lecture 2014Stevenage Bioscience Catalyst: annual lecture 2014
Stevenage Bioscience Catalyst: annual lecture 2014
 
Do you, or do you not, suspect that there is emerging a ‘good’ expla.pdf
Do you, or do you not, suspect that there is emerging a ‘good’ expla.pdfDo you, or do you not, suspect that there is emerging a ‘good’ expla.pdf
Do you, or do you not, suspect that there is emerging a ‘good’ expla.pdf
 
Science, Technology & Knowledge Economy
Science, Technology & Knowledge Economy Science, Technology & Knowledge Economy
Science, Technology & Knowledge Economy
 
2010 Mid West Science Summit | Inspiring Australia
2010 Mid West Science Summit | Inspiring Australia2010 Mid West Science Summit | Inspiring Australia
2010 Mid West Science Summit | Inspiring Australia
 
ESLTP starter workshop - survey response summary
ESLTP starter workshop - survey response summaryESLTP starter workshop - survey response summary
ESLTP starter workshop - survey response summary
 
TWAS Opportunities and the Importance of Mobilising Young Scientists in sub-S...
TWAS Opportunities and the Importance of Mobilising Young Scientists in sub-S...TWAS Opportunities and the Importance of Mobilising Young Scientists in sub-S...
TWAS Opportunities and the Importance of Mobilising Young Scientists in sub-S...
 
Science Diplomacy 101
Science Diplomacy 101Science Diplomacy 101
Science Diplomacy 101
 
Communicating Science to Policymakers
Communicating Science to PolicymakersCommunicating Science to Policymakers
Communicating Science to Policymakers
 
Overview of ESRC
Overview of ESRCOverview of ESRC
Overview of ESRC
 
Alpsp Conf 10 Sep 09
Alpsp Conf 10 Sep 09Alpsp Conf 10 Sep 09
Alpsp Conf 10 Sep 09
 
Dr andrew kaniki
Dr andrew kanikiDr andrew kaniki
Dr andrew kaniki
 
Emerging Technologies to Support an Aging Population - BlueStar TeleHealth
Emerging Technologies to Support an Aging Population - BlueStar TeleHealthEmerging Technologies to Support an Aging Population - BlueStar TeleHealth
Emerging Technologies to Support an Aging Population - BlueStar TeleHealth
 
SRUK seminar 8 July 2017
SRUK seminar 8 July 2017SRUK seminar 8 July 2017
SRUK seminar 8 July 2017
 
{The best technology in number position 2
{The best technology in number position 2{The best technology in number position 2
{The best technology in number position 2
 
{The best technology in number position 3
{The best technology in number position 3{The best technology in number position 3
{The best technology in number position 3
 

More from Biocat, BioRegion of Catalonia

Informe de la BiRegió de Catalunya 2020
Informe de la BiRegió de Catalunya 2020Informe de la BiRegió de Catalunya 2020
Informe de la BiRegió de Catalunya 2020
Biocat, BioRegion of Catalonia
 
Catalonia BioRegion report 2020
Catalonia BioRegion report 2020Catalonia BioRegion report 2020
Catalonia BioRegion report 2020
Biocat, BioRegion of Catalonia
 
Biocat presentation
Biocat presentationBiocat presentation
Biocat presentation
Biocat, BioRegion of Catalonia
 
2019 BioRegion of Catalonia Presentation
2019 BioRegion of Catalonia Presentation2019 BioRegion of Catalonia Presentation
2019 BioRegion of Catalonia Presentation
Biocat, BioRegion of Catalonia
 
Design Health Barcelona Presentation 2019
Design Health Barcelona Presentation 2019Design Health Barcelona Presentation 2019
Design Health Barcelona Presentation 2019
Biocat, BioRegion of Catalonia
 
Biocat Report 2017 Presentation
Biocat Report 2017 PresentationBiocat Report 2017 Presentation
Biocat Report 2017 Presentation
Biocat, BioRegion of Catalonia
 
Innovation, Entrepreneurship & Network Thinking: A Growth Model for the Catal...
Innovation, Entrepreneurship & Network Thinking: A Growth Model for the Catal...Innovation, Entrepreneurship & Network Thinking: A Growth Model for the Catal...
Innovation, Entrepreneurship & Network Thinking: A Growth Model for the Catal...
Biocat, BioRegion of Catalonia
 
Public session: Lessons learned from successful medtech entrepreneurs - CRAAS...
Public session: Lessons learned from successful medtech entrepreneurs - CRAAS...Public session: Lessons learned from successful medtech entrepreneurs - CRAAS...
Public session: Lessons learned from successful medtech entrepreneurs - CRAAS...
Biocat, BioRegion of Catalonia
 
EIT Health Presentation | CRAASH Barcelona
EIT Health Presentation | CRAASH BarcelonaEIT Health Presentation | CRAASH Barcelona
EIT Health Presentation | CRAASH Barcelona
Biocat, BioRegion of Catalonia
 
CIMIT (Boston) Presentation | CRAASH Barcelona
CIMIT (Boston) Presentation | CRAASH BarcelonaCIMIT (Boston) Presentation | CRAASH Barcelona
CIMIT (Boston) Presentation | CRAASH Barcelona
Biocat, BioRegion of Catalonia
 
CRAASH Barcelona Presentation
CRAASH Barcelona PresentationCRAASH Barcelona Presentation
CRAASH Barcelona Presentation
Biocat, BioRegion of Catalonia
 
Toby Reid, Managing Director – BioCity Group: “How entrepreneurs can accelera...
Toby Reid, Managing Director – BioCity Group: “How entrepreneurs can accelera...Toby Reid, Managing Director – BioCity Group: “How entrepreneurs can accelera...
Toby Reid, Managing Director – BioCity Group: “How entrepreneurs can accelera...
Biocat, BioRegion of Catalonia
 
Presentation Moebio & d·HEALTH Barcelona & CRAASH 2018
Presentation Moebio & d·HEALTH Barcelona & CRAASH 2018Presentation Moebio & d·HEALTH Barcelona & CRAASH 2018
Presentation Moebio & d·HEALTH Barcelona & CRAASH 2018
Biocat, BioRegion of Catalonia
 
Presentation Moebio 2018
Presentation Moebio 2018Presentation Moebio 2018
Presentation Moebio 2018
Biocat, BioRegion of Catalonia
 
"Breaking up pharma´s value chain - what can we expect", MICHAEL MÜLLER
"Breaking up pharma´s value chain - what can we expect", MICHAEL MÜLLER"Breaking up pharma´s value chain - what can we expect", MICHAEL MÜLLER
"Breaking up pharma´s value chain - what can we expect", MICHAEL MÜLLER
Biocat, BioRegion of Catalonia
 
"Successful model of public and private collaboration: MaRS", ZAYNA KHAYAT
"Successful model of public and private collaboration: MaRS", ZAYNA KHAYAT"Successful model of public and private collaboration: MaRS", ZAYNA KHAYAT
"Successful model of public and private collaboration: MaRS", ZAYNA KHAYAT
Biocat, BioRegion of Catalonia
 
"A new role for government in accelerating life science innovation: The Massa...
"A new role for government in accelerating life science innovation: The Massa..."A new role for government in accelerating life science innovation: The Massa...
"A new role for government in accelerating life science innovation: The Massa...
Biocat, BioRegion of Catalonia
 
Digital Health: “Healthcare Evolution: What is Different This Time”, VISHAL G...
Digital Health: “Healthcare Evolution: What is Different This Time”, VISHAL G...Digital Health: “Healthcare Evolution: What is Different This Time”, VISHAL G...
Digital Health: “Healthcare Evolution: What is Different This Time”, VISHAL G...
Biocat, BioRegion of Catalonia
 
HEALTH & BIO TEAM DATING
HEALTH & BIO TEAM DATINGHEALTH & BIO TEAM DATING
HEALTH & BIO TEAM DATING
Biocat, BioRegion of Catalonia
 
The BioRegion of Catalonia at BIO 2015
The BioRegion of Catalonia at BIO 2015The BioRegion of Catalonia at BIO 2015
The BioRegion of Catalonia at BIO 2015
Biocat, BioRegion of Catalonia
 

More from Biocat, BioRegion of Catalonia (20)

Informe de la BiRegió de Catalunya 2020
Informe de la BiRegió de Catalunya 2020Informe de la BiRegió de Catalunya 2020
Informe de la BiRegió de Catalunya 2020
 
Catalonia BioRegion report 2020
Catalonia BioRegion report 2020Catalonia BioRegion report 2020
Catalonia BioRegion report 2020
 
Biocat presentation
Biocat presentationBiocat presentation
Biocat presentation
 
2019 BioRegion of Catalonia Presentation
2019 BioRegion of Catalonia Presentation2019 BioRegion of Catalonia Presentation
2019 BioRegion of Catalonia Presentation
 
Design Health Barcelona Presentation 2019
Design Health Barcelona Presentation 2019Design Health Barcelona Presentation 2019
Design Health Barcelona Presentation 2019
 
Biocat Report 2017 Presentation
Biocat Report 2017 PresentationBiocat Report 2017 Presentation
Biocat Report 2017 Presentation
 
Innovation, Entrepreneurship & Network Thinking: A Growth Model for the Catal...
Innovation, Entrepreneurship & Network Thinking: A Growth Model for the Catal...Innovation, Entrepreneurship & Network Thinking: A Growth Model for the Catal...
Innovation, Entrepreneurship & Network Thinking: A Growth Model for the Catal...
 
Public session: Lessons learned from successful medtech entrepreneurs - CRAAS...
Public session: Lessons learned from successful medtech entrepreneurs - CRAAS...Public session: Lessons learned from successful medtech entrepreneurs - CRAAS...
Public session: Lessons learned from successful medtech entrepreneurs - CRAAS...
 
EIT Health Presentation | CRAASH Barcelona
EIT Health Presentation | CRAASH BarcelonaEIT Health Presentation | CRAASH Barcelona
EIT Health Presentation | CRAASH Barcelona
 
CIMIT (Boston) Presentation | CRAASH Barcelona
CIMIT (Boston) Presentation | CRAASH BarcelonaCIMIT (Boston) Presentation | CRAASH Barcelona
CIMIT (Boston) Presentation | CRAASH Barcelona
 
CRAASH Barcelona Presentation
CRAASH Barcelona PresentationCRAASH Barcelona Presentation
CRAASH Barcelona Presentation
 
Toby Reid, Managing Director – BioCity Group: “How entrepreneurs can accelera...
Toby Reid, Managing Director – BioCity Group: “How entrepreneurs can accelera...Toby Reid, Managing Director – BioCity Group: “How entrepreneurs can accelera...
Toby Reid, Managing Director – BioCity Group: “How entrepreneurs can accelera...
 
Presentation Moebio & d·HEALTH Barcelona & CRAASH 2018
Presentation Moebio & d·HEALTH Barcelona & CRAASH 2018Presentation Moebio & d·HEALTH Barcelona & CRAASH 2018
Presentation Moebio & d·HEALTH Barcelona & CRAASH 2018
 
Presentation Moebio 2018
Presentation Moebio 2018Presentation Moebio 2018
Presentation Moebio 2018
 
"Breaking up pharma´s value chain - what can we expect", MICHAEL MÜLLER
"Breaking up pharma´s value chain - what can we expect", MICHAEL MÜLLER"Breaking up pharma´s value chain - what can we expect", MICHAEL MÜLLER
"Breaking up pharma´s value chain - what can we expect", MICHAEL MÜLLER
 
"Successful model of public and private collaboration: MaRS", ZAYNA KHAYAT
"Successful model of public and private collaboration: MaRS", ZAYNA KHAYAT"Successful model of public and private collaboration: MaRS", ZAYNA KHAYAT
"Successful model of public and private collaboration: MaRS", ZAYNA KHAYAT
 
"A new role for government in accelerating life science innovation: The Massa...
"A new role for government in accelerating life science innovation: The Massa..."A new role for government in accelerating life science innovation: The Massa...
"A new role for government in accelerating life science innovation: The Massa...
 
Digital Health: “Healthcare Evolution: What is Different This Time”, VISHAL G...
Digital Health: “Healthcare Evolution: What is Different This Time”, VISHAL G...Digital Health: “Healthcare Evolution: What is Different This Time”, VISHAL G...
Digital Health: “Healthcare Evolution: What is Different This Time”, VISHAL G...
 
HEALTH & BIO TEAM DATING
HEALTH & BIO TEAM DATINGHEALTH & BIO TEAM DATING
HEALTH & BIO TEAM DATING
 
The BioRegion of Catalonia at BIO 2015
The BioRegion of Catalonia at BIO 2015The BioRegion of Catalonia at BIO 2015
The BioRegion of Catalonia at BIO 2015
 

Recently uploaded

Adhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.comAdhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.com
reignlana06
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
NephroTube - Dr.Gawad
 
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)
Josep Vidal-Alaball
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
LaniyaNasrink
 
Abortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentationAbortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentation
AksshayaRajanbabu
 
Histopathology of Rheumatoid Arthritis: Visual treat
Histopathology of Rheumatoid Arthritis: Visual treatHistopathology of Rheumatoid Arthritis: Visual treat
Histopathology of Rheumatoid Arthritis: Visual treat
DIVYANSHU740006
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
Health Advances
 
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
taiba qazi
 
The Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of RespirationThe Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of Respiration
MedicoseAcademics
 
LOOPS in orthodontics t loop bull loop vertical loop mushroom loop stop loop
LOOPS in orthodontics t loop bull loop vertical loop mushroom loop stop loopLOOPS in orthodontics t loop bull loop vertical loop mushroom loop stop loop
LOOPS in orthodontics t loop bull loop vertical loop mushroom loop stop loop
debosmitaasanyal1
 
Diabetic nephropathy diagnosis treatment
Diabetic nephropathy diagnosis treatmentDiabetic nephropathy diagnosis treatment
Diabetic nephropathy diagnosis treatment
arahmanzai5
 
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptxEar and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
rishi2789
 
Complementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLSComplementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLS
chiranthgowda16
 
Top-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India ListTop-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India List
SwisschemDerma
 
TEST BANK For Community and Public Health Nursing: Evidence for Practice, 3rd...
TEST BANK For Community and Public Health Nursing: Evidence for Practice, 3rd...TEST BANK For Community and Public Health Nursing: Evidence for Practice, 3rd...
TEST BANK For Community and Public Health Nursing: Evidence for Practice, 3rd...
Donc Test
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
rishi2789
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
Dr. Jyothirmai Paindla
 
All info about Diabetes and how to control it.
 All info about Diabetes and how to control it. All info about Diabetes and how to control it.
All info about Diabetes and how to control it.
Gokuldas Hospital
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
Holistified Wellness
 

Recently uploaded (20)

Adhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.comAdhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.com
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
 
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
 
Abortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentationAbortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentation
 
Histopathology of Rheumatoid Arthritis: Visual treat
Histopathology of Rheumatoid Arthritis: Visual treatHistopathology of Rheumatoid Arthritis: Visual treat
Histopathology of Rheumatoid Arthritis: Visual treat
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
 
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
 
The Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of RespirationThe Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of Respiration
 
LOOPS in orthodontics t loop bull loop vertical loop mushroom loop stop loop
LOOPS in orthodontics t loop bull loop vertical loop mushroom loop stop loopLOOPS in orthodontics t loop bull loop vertical loop mushroom loop stop loop
LOOPS in orthodontics t loop bull loop vertical loop mushroom loop stop loop
 
Diabetic nephropathy diagnosis treatment
Diabetic nephropathy diagnosis treatmentDiabetic nephropathy diagnosis treatment
Diabetic nephropathy diagnosis treatment
 
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptxEar and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
 
Complementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLSComplementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLS
 
Top-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India ListTop-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India List
 
TEST BANK For Community and Public Health Nursing: Evidence for Practice, 3rd...
TEST BANK For Community and Public Health Nursing: Evidence for Practice, 3rd...TEST BANK For Community and Public Health Nursing: Evidence for Practice, 3rd...
TEST BANK For Community and Public Health Nursing: Evidence for Practice, 3rd...
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
 
All info about Diabetes and how to control it.
 All info about Diabetes and how to control it. All info about Diabetes and how to control it.
All info about Diabetes and how to control it.
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
 

“Does Catalonia need a Chief Scientist?”, MEHRDAD HARIRI

  • 1. Does Catalonia Need a Chief Science Officer / Advisor ? Mehrdad Hariri CEO & Founder Canadian Science Policy Centre BioCat Forum Nov. 25 2016
  • 4.
  • 5.
  • 6.
  • 7.
  • 8.
  • 9.
  • 10.
  • 11. New institutions of science policy
  • 12.
  • 13. Bosch-Capblanch X, Lavis JN, Lewin S, Atun R, Røttingen J-A, Dröschel D, et al. (2012) Guidance for Evidence-Informed Policies about Health Systems: Rationale for and Challenges of Guidance Development. PLoS Med 9(3): e1001185. doi:10.1371/journal.pmed.1001185
  • 14. Cycle of Interaction: Science Society Policy Maker Adopted from: http://weadapt.org/
  • 15.
  • 16.
  • 17. • the complexity, multidisciplinary, and ever-changing nature of science and technology of the 21st century requires efficient, energetic and agile institutions to ensure the interconnection among various elements of innovation system, including the society at large.
  • 18.
  • 19.
  • 20.
  • 22.
  • 23. Why science adviser / officer
  • 24. Officer vs Advisor Chief Science Officer (CSO) Chief Science Advisor (CSA) Responsible for capacity development of the overall science enterprise or government funded science Responsible for providing independent scientific advice to the Prime Minister and the cabinet
  • 25. Officer vs Advisor Chief Science Officer (CSO) Chief Science Advisor (CSA) Responsible for capacity development of the overall science enterprise or government funded science Responsible for providing independent scientific advice to the Prime Minister and the cabinet Jurisdiction: Policy for Science Jurisdiction: Science for Policy
  • 26. Officer vs Advisor Chief Science Officer (CSO) Chief Science Advisor (CSA) Responsible for capacity development of the overall science enterprise or government funded science Responsible for providing independent scientific advice to the Prime Minister and the cabinet Jurisdiction: Policy for Science Jurisdiction: Science for Policy Ensures the well-being of the science enterprise, its management, coordination, and collaboration, domestically and internationally Provides the best scientific advice on emerging matters for high-level decision- making.
  • 27. Officer vs Advisor Chief Science Officer (CSO) Chief Science Advisor (CSA) Responsible for capacity development of the overall science enterprise or government funded science Responsible for providing independent scientific advice to the Prime Minister and the cabinet Jurisdiction: Policy for Science Jurisdiction: Science for Policy CEO of Science Enterprise/ or Government Science (depending on the extension of mandate) No Formal Executive Responsibility Ensures the well-being of the science enterprise, its management, coordination, and collaboration, domestically and internationally Provides the best scientific advice on emerging matters for high-level decision- making.
  • 28. Officer vs Advisor Chief Science Officer (CSO) Chief Science Advisor (CSA) Responsible for capacity development of the overall science enterprise or government funded science Responsible for providing independent scientific advice to the Prime Minister and the cabinet Jurisdiction: Policy for Science Jurisdiction: Science for Policy CEO of Science Enterprise/ or Government Science (depending on the extension of mandate) No Formal Executive Responsibility Functions as part of the Ministry of Science and or Innovation Independent, Arm’s Length office, functioning under the PMO Ensures the well-being of the science enterprise, its management, coordination, and collaboration, domestically and internationally Provides the best scientific advice on emerging matters for high-level decision- making.
  • 29. Science Advisory: USA The Office of Science and Technology Policy (OSTP) is a department of the United States government, part of the Executive Office of the President (EOP), established by the United States Congress in 1976, broad mandate to advise the President on the effects of science and technology on domestic and international affairs.
  • 30. Science Advisory: USA Mission: 1.To provide the President and his senior staff with accurate, relevant, and timely scientific and technical advice on all matters of consequence; 2.To ensure that the policies of the Executive Branch are informed by sound science 3.Too ensure that the scientific and technical work of the Executive Branch is properly coordinated so as to provide the greatest benefit to society.
  • 31.
  • 32. Science Advisory: UK Every government department has a chief scientific Advisor (CSA). Departmental CSAs work together under the leadership of the Government’s Chief Scientific Advisor to support each other and to address and advise on cross-cutting issues. They do this primarily through the Chief Scientific Advisors network. The network advises the Government Chief Scientific Advisor on all aspects of policy on science and technology.
  • 33. Science Advisory: UK In particular, they: 1. Provide advice to ministers, through the Cabinet committee system 2. Discuss and facilitate implementation of policy on science, technology, engineering and mathematics (STEM) 3. Identify and share good practices in STEM-related areas, including the use of scientific advice in policy-making 4. Facilitate communication on particular high profile STEM-related issues and those posing new challenges for government
  • 35. Science Advisory: New Zealand The primary task of the Chief Scientific Advisor is to provide the Prime Minister strategic and operational advice on science and science policy issues. Other tasks include: 1.Advise on matters of science policy in areas where the Prime Minister specifically requests.  2.Advise Prime Minister on specific matters related to science 3.Promote the public understanding of, and engagement with, science, particularly with young people. 4.Build international relationships. Science can be an important diplomatic tool, generating trust and confidence between nations and opening strategic opportunities for cooperation. 5.Serve as a conduit of alerts that might arise where scientific progress shows either opportunity or threat for New Zealand. 
  • 37. Science Advisory: Australia The world, and Australia with it, is faced with increasingly complex challenges and opportunities, most of which require significant input from science in order to address them fully and appropriately. It is essential then, that the Australian available, to be used to help inform the best course of action for Australian Government has access to the highest calibre independent, and authoritative scientific advice. The Chief Scientist has the opportunity to help bring together extensive national and international scientific networks to assist in providing the most up to date and scientifically robust advice. Through international networks the Chief Scientist is also able to help discuss and affect this at a global level. This is a key and unique aspect of the role.
  • 38. Science and Technology and innovation Council (STIC)
  • 40. Scotland Provides expert scientific advice to the Scottish Government about science-related issues, evidence and new developments that may have an impact on the Scottish Government's work Champions the use of science to inform policy development across the Scottish Government Supports Scotland's world-leading science base and its potential to benefit Scotland's economy, people and environment
  • 41. Quebec •To advise the Minister of Economy, Science and Innovation on matters pertaining to the development of research and science; •To chair the Boards of Directors of each of the three research funds; •To coordinate issues of common concern to the three funds and cross-sectoral research activities; •To ensure the consolidation and integration of the three research funds’ administrative activities; •To promote careers in research and scientific culture.
  • 42. Does Catalonia Need a Chief Science Officer / Advisor ?
  • 43. Determinant of such office • Objectives • Stakeholders consultation
  • 44. Innovation Systems Adopted from: Review of federal support for R&D